KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Invested Capital (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Invested Capital readings, the most recent being $94.9 billion for Q1 2026.

  • On a quarterly basis, Invested Capital rose 13.84% to $94.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $94.9 billion, a 13.84% increase, with the full-year FY2025 number at $92.6 billion, up 14.84% from a year prior.
  • Invested Capital hit $94.9 billion in Q1 2026 for Thermo Fisher Scientific, up from $92.6 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $94.9 billion in Q1 2026 to a low of $72.4 billion in Q3 2022.
  • Median Invested Capital over the past 5 years was $80.9 billion (2024), compared with a mean of $81.5 billion.
  • Biggest five-year swings in Invested Capital: soared 37.91% in 2022 and later decreased 1.02% in 2024.
  • Thermo Fisher Scientific's Invested Capital stood at $78.3 billion in 2022, then rose by 4.01% to $81.5 billion in 2023, then dropped by 1.02% to $80.6 billion in 2024, then increased by 14.84% to $92.6 billion in 2025, then increased by 2.48% to $94.9 billion in 2026.
  • The last three reported values for Invested Capital were $94.9 billion (Q1 2026), $92.6 billion (Q4 2025), and $86.5 billion (Q3 2025) per Business Quant data.